Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2015) | Total Docs. (3years) | Total Refs. (2015) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2015) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Progress in Medicinal Chemistry | journal | 1.504 Q1 | 38 | 6 | 16 | 705 | 71 | 0 | 5.00 | 117.50 |  |
| 52 | Diabetes, Metabolic Syndrome and Obesity | journal | 1.463 Q1 | 64 | 57 | 153 | 2744 | 697 | 149 | 4.77 | 48.14 |  |
| 53 | Pharmacogenomics Journal | journal | 1.449 Q1 | 95 | 74 | 216 | 3122 | 914 | 216 | 4.29 | 42.19 |  |
| 54 | Current Neuropharmacology | journal | 1.392 Q1 | 103 | 77 | 127 | 8032 | 534 | 118 | 4.09 | 104.31 |  |
| 55 | Antiviral Therapy | journal | 1.388 Q1 | 93 | 107 | 425 | 3198 | 1177 | 409 | 2.76 | 29.89 | |
| 56 | Investigational New Drugs | journal | 1.388 Q1 | 97 | 141 | 589 | 4514 | 2082 | 586 | 3.71 | 32.01 | |
| 57 | Journal of Natural Products | journal | 1.382 Q1 | 161 | 402 | 1040 | 14212 | 4623 | 1034 | 4.00 | 35.35 |  |
| 58 | Experimental and Clinical Psychopharmacology | journal | 1.373 Q1 | 101 | 54 | 173 | 2893 | 527 | 170 | 2.48 | 53.57 | |
| 59 | Drug Safety | journal | 1.365 Q1 | 140 | 104 | 320 | 5108 | 1101 | 281 | 3.60 | 49.12 | |
| 60 | Current Molecular Pharmacology | journal | 1.354 Q1 | 49 | 35 | 77 | 3169 | 231 | 67 | 2.03 | 90.54 | |
| 61 | Expert Opinion on Investigational Drugs | journal | 1.341 Q1 | 117 | 132 | 440 | 11218 | 1719 | 434 | 3.84 | 84.98 | |
| 62 | Drug Metabolism and Disposition | journal | 1.321 Q1 | 194 | 220 | 769 | 9767 | 2839 | 758 | 3.56 | 44.40 | |
| 63 | Altex | journal | 1.320 Q1 | 64 | 36 | 127 | 1912 | 477 | 103 | 3.80 | 53.11 |  |
| 64 | Cancer Biology and Therapy | journal | 1.313 Q1 | 130 | 208 | 520 | 8550 | 1641 | 488 | 2.95 | 41.11 | |
| 65 | Perspectives in Medicinal Chemistry | journal | 1.285 Q1 | 17 | 3 | 5 | 193 | 29 | 5 | 5.80 | 64.33 | |
| 66 | Cancer Chemotherapy and Pharmacology | journal | 1.266 Q1 | 122 | 280 | 889 | 8763 | 2864 | 877 | 3.26 | 31.30 | |
| 67 | Infection and Drug Resistance | journal | 1.263 Q1 | 65 | 39 | 82 | 2276 | 321 | 82 | 4.32 | 58.36 | |
| 68 | Cardiovascular Therapeutics | journal | 1.259 Q1 | 54 | 50 | 192 | 1995 | 578 | 181 | 2.50 | 39.90 | |
| 69 | Current Pharmaceutical Design | journal | 1.242 Q1 | 183 | 614 | 1877 | 67431 | 6187 | 1727 | 3.19 | 109.82 | |
| 70 | Cardiovascular Drugs and Therapy | journal | 1.238 Q1 | 79 | 68 | 204 | 3278 | 526 | 166 | 2.82 | 48.21 | |
| 71 | Current Drug Targets | journal | 1.219 Q1 | 119 | 177 | 486 | 17651 | 1577 | 451 | 3.19 | 99.72 | |
| 72 | Vascular Pharmacology | journal | 1.208 Q1 | 108 | 118 | 211 | 6233 | 677 | 197 | 2.64 | 52.82 | |
| 73 | Pharmacogenomics and Personalized Medicine | journal | 1.195 Q1 | 37 | 15 | 63 | 858 | 275 | 63 | 4.46 | 57.20 | |
| 74 | Human gene therapy methods | journal | 1.192 Q1 | 38 | 28 | 114 | 817 | 293 | 114 | 2.20 | 29.18 | |
| 75 | Expert Opinion on Biological Therapy | journal | 1.180 Q1 | 102 | 177 | 508 | 12702 | 1830 | 494 | 3.67 | 71.76 | |
| 76 | Pharmaceutical Statistics | journal | 1.180 Q1 | 46 | 57 | 160 | 1388 | 177 | 149 | 1.20 | 24.35 | |
| 77 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.164 Q1 | 82 | 15 | 42 | 2911 | 243 | 42 | 5.67 | 194.07 | |
| 78 | Prostaglandins and Other Lipid Mediators | journal | 1.162 Q1 | 86 | 69 | 132 | 4165 | 382 | 128 | 3.10 | 60.36 | |
| 79 | Pharmaceutical Research | journal | 1.155 Q1 | 229 | 308 | 822 | 13837 | 3340 | 811 | 3.90 | 44.93 | |
| 80 | Journal of Ethnopharmacology | journal | 1.152 Q1 | 231 | 706 | 1975 | 38624 | 7718 | 1957 | 3.62 | 54.71 |  |
| 81 | ChemMedChem | journal | 1.151 | 119 | 222 | 773 | 9007 | 2167 | 760 | 2.64 | 40.57 | |
| 82 | European Journal of Clinical Pharmacology | journal | 1.146 Q1 | 123 | 182 | 664 | 6280 | 2036 | 583 | 2.97 | 34.51 | |
| 83 | European Journal of Medicinal Chemistry | journal | 1.143 Q1 | 203 | 771 | 2214 | 40279 | 9135 | 2212 | 4.15 | 52.24 |  |
| 84 | PharmacoEconomics | journal | 1.143 Q1 | 118 | 105 | 294 | 5466 | 733 | 245 | 2.44 | 52.06 | |
| 85 | Acta Pharmacologica Sinica | journal | 1.136 Q1 | 117 | 152 | 548 | 7530 | 1739 | 538 | 3.12 | 49.54 | |
| 86 | Pharmacology Biochemistry and Behavior | journal | 1.130 Q2 | 148 | 218 | 776 | 12664 | 2430 | 771 | 3.00 | 58.09 | |
| 87 | European Journal of Pharmacology | journal | 1.122 Q2 | 203 | 754 | 1852 | 38814 | 5824 | 1846 | 3.14 | 51.48 | |
| 88 | Therapeutic Advances in Neurological Disorders | journal | 1.113 Q2 | 68 | 30 | 84 | 1534 | 329 | 81 | 3.50 | 51.13 | |
| 89 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.110 Q2 | 57 | 60 | 177 | 2823 | 515 | 172 | 3.10 | 47.05 | |
| 90 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 1.095 Q2 | 92 | 139 | 403 | 5786 | 1330 | 402 | 3.29 | 41.63 | |
| 91 | Expert Opinion on Therapeutic Patents | journal | 1.081 Q2 | 88 | 114 | 314 | 8332 | 1340 | 313 | 4.59 | 73.09 | |
| 92 | Journal of Biomolecular Screening | journal | 1.080 Q2 | 86 | 126 | 397 | 4930 | 1015 | 394 | 2.48 | 39.13 | |
| 93 | Clinical Therapeutics | journal | 1.053 Q2 | 150 | 270 | 644 | 9992 | 1938 | 573 | 2.83 | 37.01 | |
| 94 | Core Evidence (discontinued) | journal | 1.051 Q2 | 29 | 8 | 32 | 471 | 130 | 31 | 4.30 | 58.88 | |
| 95 | Expert Opinion on Emerging Drugs | journal | 1.051 Q2 | 54 | 50 | 125 | 4861 | 374 | 122 | 2.58 | 97.22 | |
| 96 | Microbial Drug Resistance | journal | 1.040 Q2 | 78 | 91 | 256 | 3418 | 652 | 241 | 2.70 | 37.56 | |
| 97 | Inflammopharmacology | journal | 1.031 Q2 | 68 | 32 | 113 | 1955 | 365 | 105 | 2.75 | 61.09 |  |
| 98 | Pharmacognosy Reviews (discontinued) | journal | 1.019 Q2 | 68 | 24 | 65 | 1200 | 259 | 65 | 3.73 | 50.00 |  |
| 99 | Phytomedicine | journal | 1.007 Q2 | 141 | 162 | 613 | 5467 | 2239 | 600 | 3.40 | 33.75 | |
| 100 | Journal of Clinical Pharmacology | journal | 0.993 Q2 | 130 | 186 | 550 | 5879 | 1511 | 515 | 2.83 | 31.61 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data